Clinical Trial Update: A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update shows ALE.P03 as monotherapy being studied in adults with selected advanced or metastatic CLDN1+ solid tumors, currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Squamous Cell Carcinoma
• Colorectal Cancer
• Intrahepatic Cholangiocarcinoma
• Squamous Cell Non-small Cell Lung Cancer
• Urothelial Carcinoma

Drugs mentioned

• ALE.P03

Snippet

Sponsor: Alentis Therapeutics AG | Conditions: Cervical Squamous Cell Carcinoma, Squamous Non-small-cell Lung Cancer | Phase 1, Phase 2 | Status: RECRUITING